Antoine F. Carpentier

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Ahmed Idbaih

Sorbonne Université

FRANCE

View details

Christine MORONI

Professor of Neuropsychology

Université de Lille

FRANCE

View details

PEDRO RUIZ-ARTACHO

Profesor Colaborador

Universidad de Navarra

SPAIN

View details

Paul Mulholland

Associate Professor

University College London

UNITED KINGDOM

View details

raquel barba

Professor

Universidad Rey Juan Carlos - Campus de Móstoles

SPAIN

View details

Guillaume Darrasse-Jeze

Associate Professor, Inserm Chair of Biotherapies

Université de Paris Faculté de Santé

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antoine F. Carpentier

Research Interests

Explore related searches

Contact this professor

Articles (10)

2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.

Radiotherapy Combined With Nivolumab or Temozolomide for Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter: An International Randomized Phase 3 Trial.

Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade <i>IDH</i>-Mutant Gliomas: A French POLA Network Study.

Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy

Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment.

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.

Evaluation of mid-term (6-12 months) neurotoxicity in B-cell lymphoma patients treated with CAR T cells: a prospective cohort study

First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer.

Diabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.

Collaborators (6)

Ahmed Idbaih

Christine MORONI

PEDRO RUIZ-ARTACHO

Paul Mulholland

raquel barba

Guillaume Darrasse-Jeze

Make your next move.